Nature

Intravitreal triamcinolone and bevacizumab combination therapy for macular edema due to central retinal vein occlusion refractory to either treatment alone

A review of the literature showed no published cases using a combination of intravitreal triamcinolone and anti-VEGF agents for macular edema due to central retinal vein occlusion (CRVO). We present a ...
Nature

Intravitreal triamcinolone will cause posterior subcapsular cataract in most eyes with diabetic maculopathy within 2 years

Prospective, non-randomised, interventional cohort case series. A total of 27 eyes of 27 patients with diabetic macular oedema received an intravitreal injection of 4 mg (0.1 ml) of triamcinolone ...
Healio

Intravitreal triamcinolone for macular diseases safe in study in Chinese patients

Please provide your email address to receive an email when new articles are posted on . A single 4 mg bolus injection of intravitreal triamcinolone seemed to have no harmful effects on the corneal ...
Ophthalmology Times

Phase I/II study finds intravitreal CD34+ stem cells safe and feasible in CRVO

A newly published study found that intravitreal injection of autologous CD34+ stem cells is well tolerated and feasible for treating loss of vision resulting from central retinal vein occlusion (CRVO) ...
Healio

Triamcinolone acetonide-moxifloxacin controls inflammation after cataract surgery

Please provide your email address to receive an email when new articles are posted on . The retrospective longitudinal comparative study included 681 eyes (group 1) that received Tri-Moxi ...
Medscape

Intravitreal Aflibercept Use in the Treatment of Macular Edema From Central Retinal Vein Occlusion

Expert Rev Ophthalmol. 2013;8(3):227-235. The use of anti-VEGF is rapidly becoming the standard of care for retinal vascular disease. There remains some concern regarding the duration of treatment; ...